Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

Vicore Pharma Holding AB (publ) VCRE

Full chart Compare
Set alert

Price alert · VCRE

All alert types
11.27 USD +0.87 (+8.37%)

At closeNov 9, 2026, 4:00 PM EST

11.23 -0.04 -0.35%

After hours · Nov 9, 4:00 PM ET

10.68 Day range 11.30
7.88 52-week range 17.80
YTD
-30.65%
1 year
-30.65%

Revenue & Expenses

Other Income → Expenses: $23.89MOther Operating Income → Expenses: $2.06MExpenses → Selling, General & Admin: $67.91MExpenses → Research & Development: $390.35MExpenses → Interest Expense: $48.98MGross Profit → Expenses: $3.82MRevenue → Gross Profit: $3.82MNet Loss → Expenses: $477.47MOther Income$23.89MOther Operating Income$2.06MGross Profit$3.82MNet Loss$477.47MExpenses$507.24MSelling, General & Admin$67.91MResearch & Development$390.35MInterest Expense$48.98MRevenue$3.82M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Income statement

Full income statement How to read it
VCRE annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023
3.82M109.35M0
3.82M109.35M0
-452.39M-194.19M-321.51M
-477.47M-168.63M-310.94M
-1.99-1.23-3.18

Balance sheet

Full balance sheet How to read it
VCRE annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023
578.15M1.16B—
1.19B1.18B—
98.05M54.56M—
1.10B1.13B—

Cash flow

Full cash flow How to read it
VCRE annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023
-375.74M-164.95M-249.58M
-600.51M149.04M-144.46M
430.54M834.06M470.86M
-545.70M818.15M76.82M